BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 24793143)

  • 1. Computational analysis of negative and positive allosteric modulator binding and function in metabotropic glutamate receptor 5 (in)activation.
    Dalton JA; Gómez-Santacana X; Llebaria A; Giraldo J
    J Chem Inf Model; 2014 May; 54(5):1476-87. PubMed ID: 24793143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric Binding Site and Activation Mechanism of Class C G-Protein Coupled Receptors: Metabotropic Glutamate Receptor Family.
    Feng Z; Ma S; Hu G; Xie XQ
    AAPS J; 2015 May; 17(3):737-53. PubMed ID: 25762450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Acting at Site Distinct from 2-Methyl-6-(phenylethynyl)-pyridine Binding.
    Butkiewicz M; Rodriguez AL; Rainey SE; Wieting J; Luscombe VB; Stauffer SR; Lindsley CW; Conn PJ; Meiler J
    ACS Chem Neurosci; 2019 Aug; 10(8):3427-3436. PubMed ID: 31132237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the interaction of negative allosteric modulators with the metabotropic glutamate receptor 5: discovery and computational modeling of a new series of ligands with nanomolar affinity.
    Anighoro A; Graziani D; Bettinelli I; Cilia A; De Toma C; Longhi M; Mangiarotti F; Menegon S; Pirona L; Poggesi E; Riva C; Rastelli G
    Bioorg Med Chem; 2015 Jul; 23(13):3040-58. PubMed ID: 26014480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 7TM X-ray structures for class C GPCRs as new drug-discovery tools. 1. mGluR5.
    Topiol S; Sabio M
    Bioorg Med Chem Lett; 2016 Jan; 26(2):484-494. PubMed ID: 26706173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtype-selective mechanisms of negative allosteric modulators binding to group I metabotropic glutamate receptors.
    Fu TT; Tu G; Ping M; Zheng GX; Yang FY; Yang JY; Zhang Y; Yao XJ; Xue WW; Zhu F
    Acta Pharmacol Sin; 2021 Aug; 42(8):1354-1367. PubMed ID: 33122823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-{4-Chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide (CPPHA) acts through a novel site as a positive allosteric modulator of group 1 metabotropic glutamate receptors.
    Chen Y; Goudet C; Pin JP; Conn PJ
    Mol Pharmacol; 2008 Mar; 73(3):909-18. PubMed ID: 18056795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric Modulation Mechanism of the mGluR
    Cong X; Chéron JB; Golebiowski J; Antonczak S; Fiorucci S
    J Chem Inf Model; 2019 Jun; 59(6):2871-2878. PubMed ID: 31025859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shining Light on an mGlu5 Photoswitchable NAM: A Theoretical Perspective.
    Dalton JA; Lans I; Rovira X; Malhaire F; Gómez-Santacana X; Pittolo S; Gorostiza P; Llebaria A; Goudet C; Pin JP; Giraldo J
    Curr Neuropharmacol; 2016; 14(5):441-54. PubMed ID: 26391742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the metabotropic glutamate receptor 5 (mGlu₅) positive allosteric modulator (PAM) binding pocket: discovery of point mutations that engender a "molecular switch" in PAM pharmacology.
    Gregory KJ; Nguyen ED; Reiff SD; Squire EF; Stauffer SR; Lindsley CW; Meiler J; Conn PJ
    Mol Pharmacol; 2013 May; 83(5):991-1006. PubMed ID: 23444015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling the Structural Determinants of Aryl Benzamide Derivatives as Negative Allosteric Modulators of mGluR5 by In Silico Study.
    Zhao Y; Chen J; Liu Q; Li Y
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31963723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probe dependence and biased potentiation of metabotropic glutamate receptor 5 is mediated by differential ligand interactions in the common allosteric binding site.
    Hellyer SD; Sengmany K; Keller AN; Christopoulos A; Leach K; Gregory KJ
    Biochem Pharmacol; 2020 Jul; 177():114013. PubMed ID: 32389635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurophysiological signals as potential translatable biomarkers for modulation of metabotropic glutamate 5 receptors.
    Harvey BD; Siok CJ; Kiss T; Volfson D; Grimwood S; Shaffer CL; Hajós M
    Neuropharmacology; 2013 Dec; 75():19-30. PubMed ID: 23831682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modelling studies on ɑ7 nicotinic receptor allosteric modulators yields novel filter-based virtual screening protocol.
    Al Rawashdah S; Hamrouni A; Sadek B; Amer R; Metwaly M; Atatreh N; Ghattas MA
    J Mol Graph Model; 2019 Nov; 92():44-54. PubMed ID: 31306865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of a positive allosteric modulator CDPPB to metabotropic glutamate receptor type 5 (mGluR5) probed by all-atom molecular dynamics simulations.
    Uba AI; Chea J; Hoag H; Hryb M; Bui-Linh C; Wu C
    Life Sci; 2022 Nov; 309():121014. PubMed ID: 36179814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery, synthesis, and structure-activity relationships of 2-aminoquinazoline derivatives as a novel class of metabotropic glutamate receptor 5 negative allosteric modulators.
    Kubas H; Meyer U; Krueger B; Hechenberger M; Vanejevs M; Zemribo R; Kauss V; Ambartsumova R; Pyatkin I; Polosukhin AI; Abel U
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4493-500. PubMed ID: 23856046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer-aided design of negative allosteric modulators of metabotropic glutamate receptor 5 (mGluR5): Comparative molecular field analysis of aryl ether derivatives.
    Selvam C; Thilagavathi R; Narasimhan B; Kumar P; Jordan BC; Ranganna K
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1140-4. PubMed ID: 26826734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic and system bias as drivers of metabotropic glutamate receptor 5 allosteric modulator pharmacology.
    Sengmany K; Hellyer SD; Albold S; Wang T; Conn PJ; May LT; Christopoulos A; Leach K; Gregory KJ
    Neuropharmacology; 2019 May; 149():83-96. PubMed ID: 30763654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based discovery and development of metabotropic glutamate receptor 5 negative allosteric modulators.
    Bennett KA; Christopher JA; Tehan BG
    Adv Pharmacol; 2020; 88():35-58. PubMed ID: 32416871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxazolidinone-based allosteric modulators of mGluR5: Defining molecular switches to create a pharmacological tool box.
    Huang H; Degnan AP; Balakrishnan A; Easton A; Gulianello M; Huang Y; Matchett M; Mattson G; Miller R; Santone KS; Senapati A; Shields EE; Sivarao DV; Snyder LB; Westphal R; Whiterock VJ; Yang F; Bronson JJ; Macor JE
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4165-9. PubMed ID: 27496211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.